Combo Therapy Sustains Bone-Density ImprovementsCombo Therapy Sustains Bone-Density Improvements

Two-year results of a combination of denosumab and teriparatide therapy show sustained improvements in bone-mineral density that exceed that expected with either drug alone. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news